fluids were analyzed by high pressure liquid chromatography (HPLC) as reported previously [9] .
Fluoroquinolone is becoming an important antibacterial agent because of its broad antibacterial activity in veterinary practice [6] . The antibacterial agents are effective against most of the gram-negative and part of the gram-positive pathogenic bacteria [3] as well as Mycoplasma spp. and Chlamydia spp. [10, 11] . Norfloxacin nicotinate (NFLXN) is a water soluble version of norfloxacin [12] which is used the bacterial treatment in various animals. The formulation has been registered for veterinary use in several countries including Korea. NFLXN is commercially available as a dry powder for dissolving in drinking water and a sterile injectable solution for industrial animals. In a previous report, we described the pharmacokinetics of newly formulated norfloxacin-glycine acetate (NFLXGA) for flounder [8] . NFLXGA is more soluble in water than NFLXN [9] , this characteristic makes it to use for oral administration in pigs and chickens. However, the pharmacokinetics of NFLXGA have not been studied in mammals, including rabbits. Therefore, the objective of the present study was to establish the pharmacokinetic profiles of newly developed NFLXGA after oral administration, and compared them with those for NFLXN used for the rabbits. In addition, the tissue distributions of both formulations were checked after oral administration of the same dose.
The experiments were conducted on 20 clinically healthy male New Zealand White rabbits, with a body weight of 1.5 ± 0.5 kg. The rabbits received no medication for at least 2 weeks before the experiment. They had free access to water. For the comparative pharmacokinetic studies of NFLX, NFLXN and NFLXGA, six rabbits were used in a 3-way crossover study with a sufficient wash-out period of two week intervals. Each rabbit was dosed at the rate of 5 mg per kg body weight via oral and intravenous administration. Blood samples were collected at 0, 15, 30, 45, 60, 90, 120, 180, 240, 300, 360, 420 and 480 min with a heparinized Microvett 300 ® . A 100-µl plasma sample was deproteinated with 100 µl of 20% cold trichloroacetic acid in methanol and centrifuged at 15,000 rpm for 5 min. The supernatant phramacokinetic model of NFLX in the study is very similar to that described in horses [7] , the normal donkey [4] and dogs [5] . After i.v. injection of NFLX, the elimination halflife (T 1/2β ) of 3.37 ± 1.37 hr in this study was similar to half-lives reported for mice, rats, dogs and monkeys [5] , but shorter than the half-lives reported for horses [7] , calves [13] and human beings [2] . The systemic clearance (Cl B ) of NFLX was 0.68 ± 0.18 l/kg/hr and the volume of distribution of NFLX at steady state (VD ss ) was 2.21 ± 1.07 L/kg. After oral administration of NFLX and NFLX formulations, the T 1/2β of NFLX (3.37 ± 1.37 hr) was not significantly different from those of NFLXN (3.61 ± 0.65 hr) and NFLXGA (3.39 ± 1.54 hr). The maximal concentration (C max ) values in plasma of NFLX, NFLXN and NFLXGA showed 0.68 ± 0.05, 0.81 ± 0.39 and 0.82 ± 0.26 µg/ml, respectively with not significant difference. The area under curve (AUC) of NFLX, NFLXN and NFLXGA was 2.28 ± 0.75, 3.58 ± 0.85 and 3.20 ± 0.57 µg·hr/ml (p<0.05), respectively. From the AUC's values, the absolute bioavailability (F) of these products was NFLXN, 45%, NFLXGA, 40%, and NFLX was 29%. The mean volume of distribution (VD ss ) of NFLX, NFLXN and NFLXGA at steady state for the rabbits was similar to that reported for rats [5] , monkeys [5] and humans [1] .
The tissue distribution of NFLX was investigated at 2 hr after oral administration of NFLXN and NFLXGA with a dose of 5 mg/kg body weight because the maximal time (T max ) at maximal concentration was within 1 hr in the present study. Table 2 shows the NFLX concentrations in various tissues of the rabbits. From Table 2 , NFLX levels in the tissue of rabbits were 1.04-4.96 times higher for 
